Newly diagnosed AML patient samples demonstrate high degree of concordance in identification of pathogenic mutations by next generation sequencing (NGS) performed at enrolling institutions compared to central laboratory results in the Beat AML Master Trial Meeting Abstract


Authors: Borate, U.; Ruppert, A. S.; Yang, F.; Jones, D.; Caruthers, S.; Zhao, W.; Vergilio, J. A.; Burd, A.; Pavlick, D.; Juckett, L.; Stein, E. M.; Patel, P. A.; Baer, M. R.; Stock, W.; Schiller, G. J.; Blum, W.; Kovacsovics, T.; Litzow, M.; Foran, J. M.; Heerema, N. A.; Rosenberg, L.; Marcus, S.; Yocum, A. O.; Stefanos, M.; Druker, B. J.; Byrd, J. C.; Levine, R. L.; Mims, A. S.
Abstract Title: Newly diagnosed AML patient samples demonstrate high degree of concordance in identification of pathogenic mutations by next generation sequencing (NGS) performed at enrolling institutions compared to central laboratory results in the Beat AML Master Trial
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000577160404103
DOI: 10.1182/blood-2019-131253
PROVIDER: wos
Notes: Meeting Abstract: 2145 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein
  2. Ross Levine
    775 Levine